GINA KICOS: Open Payments
NPI 1073952685 · CANTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,200 in 71 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,200
Food & beverage: $1,058Education: $84Speaker / faculty: $57
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $420 |
| Daiichi Sankyo Inc. | 11 | $170 |
| Janssen Biotech, Inc. | 8 | $155 |
| Ardelyx, Inc. | 6 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $82 |
| QOL Medical, LLC | 3 | $63 |
| Ipsen Biopharmaceuticals, Inc | 3 | $61 |
| Braintree Laboratories, Inc. | 3 | $51 |
| Lilly USA, LLC | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
Products named: RINVOQ, INJECTAFER, TREMFYA, IBSRELA, ENTYVIO, Sucraid, IQIRVO, SKYRIZI.
Industry payments across OH — which companies pay providers there.
